Exodus Point Capital Management, LP Next Cure, Inc. Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$1.29 - $1.84 $13,188 - $18,812	-10,224 Reduced 33.33%	20,449 $26,000
Q2 2023 Aug 10, 2023	SELL	$1.47 - $1.86 $1,202 - $1,521	-818 Reduced 2.6%	30,673 $55,000
Q1 2023 May 11, 2023	SELL	$1.46 - $1.83 $5,098 - $6,390	-3,492 Reduced 9.98%	31,491 $47,000
Q4 2022 Feb 13, 2023	SELL	$1.2 - $3.07 $17,641 - $45,132	-14,701 Reduced 29.59%	34,983 $49,000
Q3 2022 Nov 10, 2022	SELL	$2.72 - $5.19 $90,178 - $172,069	-33,154 Reduced 40.02%	49,684 $137,000
Q2 2022 Aug 19, 2022	SELL	$3.38 - $5.27 $35,719 - $55,693	-10,568 Reduced 11.31%	82,838 $389,000
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $57,638 - $75,560	12,109 Added 14.89%	93,406 $454,000
Q4 2021 Feb 11, 2022	BUY	$5.7 - $9.1 $404,865 - $646,363	71,029 Added 691.75%	81,297 $488,000
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $211,979 - $252,237	-31,451 Reduced 75.39%	10,268 $69,000
Q2 2021 Aug 16, 2021	BUY	$7.6 - $10.28 $213,263 - $288,467	28,061 Added 205.45%	41,719 $335,000
Q1 2021 May 17, 2021	BUY	$9.81 - $13.88 $133,984 - $189,573	13,658 New	13,658 $137,000
Q3 2020 Nov 16, 2020	SELL	$8.15 - $21.17 $206,406 - $536,151	-25,326 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$21.19 - $40.2 $536,657 - $1.02 Million	25,326 New	25,326 $543,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $21.1M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.